Chemomab Therapeutics Ltd. (CMMB)

CIK 1534248 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Chemomab Therapeutics Ltd..

Recent SEC filings

FiledFormAccession number
Sep 9, 2026SCHEDULE 13D/A0001104659-26-106301
Sep 1, 202640001178913-26-004371
Aug 19, 20266-K0001178913-26-004193
Aug 13, 2026SCHEDULE 13G0002148623-26-000001
Aug 10, 2026SCHEDULE 13G/A0001995601-26-000004
Jul 16, 2026SCHEDULE 13D0001104659-26-084244
Jul 8, 20266-K0001178913-26-003442
Jun 3, 202630001178913-26-003083
Jun 2, 20266-K0001178913-26-003058
Jun 1, 202640001178913-26-003004
May 14, 20266-K0001178913-26-002672
May 6, 20266-K0001178913-26-002423
Apr 28, 20266-K0001178913-26-002274
Apr 10, 202630001178913-26-002068
Apr 10, 202630001178913-26-002066
Apr 10, 202630001178913-26-002062
Apr 10, 202630001178913-26-002064
Apr 10, 202630001178913-26-002060
Apr 10, 202630001178913-26-002070
Mar 31, 202630001178913-26-001962
Mar 31, 202630001178913-26-001960
Mar 23, 202620-F0001178913-26-001593
Mar 20, 20266-K0001178913-26-001571
Mar 19, 20266-K0001178913-26-001550
Feb 17, 2026SCHEDULE 13G/A0001211060-26-000005